Skip to main content
Michael Ohl, MD, Infectious Disease, Iowa City, IA

Michael E Ohl MD


Assistant Professor, Internal Medicine, University of Iowa College of Medicine

Join to View Full Profile
  • 200 Hawkins DrIowa City, IA 52242

  • Phone+1 319-356-7740

  • Fax+1 319-384-7208

Dr. Ohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Family Medicine, 2003 - 2004
  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 1999 - 2002
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • IA State Medical License
    IA State Medical License 2006 - 2026
  • WA State Medical License
    WA State Medical License 1999 - 2004
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease
  • Addiction Medicine
    American Board of Preventive Medicine Addiction Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • University of Iowa Led Observational Study Reveals Remdesivir Can Lengthen Hospital Stay & Not Contribute to Survival
    University of Iowa Led Observational Study Reveals Remdesivir Can Lengthen Hospital Stay & Not Contribute to SurvivalJuly 21st, 2021
  • Remdesivir Treatment Plan Kept COVID-19 Patients Hospitalized Longer, University of Iowa Research Shows
    Remdesivir Treatment Plan Kept COVID-19 Patients Hospitalized Longer, University of Iowa Research ShowsJuly 21st, 2021
  • Remdesivir Treatment Period for COVID-19 Patients Kept Hospital Beds Full While They Were Scarce
    Remdesivir Treatment Period for COVID-19 Patients Kept Hospital Beds Full While They Were ScarceJuly 20th, 2021
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: